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Background: Recent research has suggested that long-term pediatric cancer survivors were at 77 
risk of important physical and psychological morbidities. To date, we do not know to what extent 78 
functional health status contributes to psychological risk and which domains are most important. 79 
The aim of this study was to systematically explore which functional domain could explain 80 
anxiety, depression, and distress symptoms. 81 
Procedure: We used data available for 105 adolescents and 182 adults successfully treated for 82 
childhood acute lymphoblastic leukemia at two Canadian sites part of the PETALE cohort. 83 
Participants were ≥5 years post-diagnosis, aged 22 ± 6 yrs., 52% female, 49% ALL high-risk 84 
status. The contribution of health functional status (15D/16D questionnaires) to self-reported 85 
anxiety, depression, and distress (Beck scales and distress thermometer) was evaluated using 86 
adjusted logistic regression models. 87 
Results: Prevalence rates found for mild-severe anxiety, depression and distress were 14%, 21% 88 
and 30% among adolescents and 27%, 20% and 19% among adults. Frequent health domains 89 
associated with psychological risk were sleeping and breathing in adolescents, and 90 
vitality/fatigue, discomfort/pain, mental function, and sleeping in adults. Mental function was 91 
systematically associated with psychological risk across age groups (median OR=10.00, 95% CI 92 
3.01-33.71). Exploratory mediation bootstrapping analyses suggested that the effect on 93 
psychological risk of overall health status and mental function problems was partly explained by 94 
social/work/school functioning. 95 
Conclusion: The results identified important functional health domains that could be targeted for 96 
interventions preventing psychological risk: vitality/fatigue, discomfort/pain, sleeping, and 97 
mental function issues. Health domains probably affect mood partly by limiting 98 
social/work/school functioning.  99 
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    INTRODUCTION 100 
Significant treatment improvements in childhood acute lymphoblastic leukemia (cALL) have led 101 
to a 5-year survival rate reaching 91% in Canada1. Several studies have highlighted how 102 
radiation therapy exposure, chemotherapy toxicity, as well as sex and age at diagnosis may be 103 
contributing factors to late adverse effects (LAEs) for survivors. LAEs include metabolic 104 
dysfunctions, musculoskeletal morbidities, cardiopulmonary and neurocognitive impairments2-14. 105 
A report on the Childhood Cancer Survivor Study (CCSS) has estimated that 62% of surveyed 106 
adult survivors had at least one chronic health condition and 28% suffered from a severe 107 
condition5. Furthermore, the St-Jude Lifetime Cohort study found that the cumulative burden of 108 
chronic health conditions among adult childhood cancer survivors (CCS) compared to a 109 
community sample was also significantly higher with a high frequency of secondary neoplasms, 110 
spinal disorders, and pulmonary function deficits15. Fewer reports are available in younger 111 
survivors exclusively but a study revealed 66% of children and adolescents will have at least one 112 
chronic condition 5 to 14 years after diagnosis16.  113 
Studies exploring psychological status in adult survivors have shown higher levels of negative 114 
mood, anxiety, depression, suicide ideation, and global distress than siblings or healthy controls17-115 
22 and a risk for elevated, persistent emotional distress over time17. Although few studies have 116 
assessed mental health status of adolescents previously treated for cancer, a systematic review 117 
found 13% to 29% of this age group experienced distress23. Yet, several reports have described no 118 
heightened distress in comparison with controls24 or mixed inconclusive results25. Collecting self-119 




Importantly, the course of emotional distress seems to follow that of age and gradual expression 122 
of physical late effects16,17. Across age groups, poorer functional health status and physical 123 
symptoms were found to contribute to both emotional distress and poorer quality of life20,27-31. 124 
Key factors of emotional distress frequency or severity supported by the evidence in the CCS 125 
population include younger age or adolescent age at diagnosis, older age at recall, female sex, 126 
lower socioeconomic status, single or divorced status, lack of health insurance, poor social 127 
relationships, neurocognitive impairment, pain, fatigue, chronic condition, and an overall 128 
perception of health deterioration and physical health status8,20,22,28,32-39. Physical limitations may 129 
hinder age appropriate activities, lead to difficulties in social relationships and thus to 130 
psychological suffering7,9,40-42. Particularly, impaired neurocognitive speed and executive 131 
function may affect emotional wellbeing as they hinder social functioning and are associated 132 
with lower educational attainment, employment discrimination and unemployment9,43-45. In 133 
summary, although it is widely recognized that LAEs may have a detrimental impact on quality 134 
of life and mental health, it is still unclear which domains are most important for psychological 135 
outcomes. This is especially true for adolescents where data is scarce.  136 
The primary aim of this study was to describe psychological symptoms, specifically internalizing 137 
problems (anxiety, depression, and distress) in a homogeneous cohort of adolescent and young 138 
adult cALL survivors and identify which domains of functional health status domains were most 139 
associated with these psychological outcomes. A secondary aim was to explore to what extent 140 







    MATERIAL AND METHODS 146 
 147 
Participant Eligibility and Data Collection Procedure 148 
The study population consisted of individuals treated for cALL from the PETALE cohort at Sainte-149 
Justine University Health Center (SJUHC, Montreal, Canada) and the Laval University Health 150 
Center (CHUL, Quebec, Canada). Eligibility was determined based on the following criteria: ALL 151 
diagnosis before the age of 19, DFCI treatment protocol, ≥5 years from diagnosis with no 152 
recurrence, have not undergone hematopoietic stem cell transplantation, French or English 153 
speaking, and ability to complete self-rated questionnaires. 154 
Data was collected among adolescents (13-18 years) and young adults (19+ years). Participants 155 
were asked to complete the measures presented below on site or, if not possible, at home and 156 
returned by mail. Ethical approvals for this cohort recall were obtained through both sites’ review 157 
boards. Full details on the study design are available in a previous report10. 158 
 159 
Sociodemographic and clinical data 160 
Sociodemographic data was obtained using a study-specific questionnaire and included key 161 
descriptors such as current age and sex. Cancer-related data such as age at diagnosis and clinical 162 
history were collected from medical files. 163 
 164 
Assessment of anxiety, depression, and distress  165 
The psychological status of participants was assessed using standardized instruments. To assess 166 
anxiety and depression symptoms, the Beck self-rated inventories were selected as they are widely 167 
used in clinical research to measure anxiety and depression symptom severity and offer 168 
opportunity of a consistent definition across ages. The Beck Youth Inventories for Anxiety and 169 
Depression (BYI-AD)46 were administered to adolescents . These 20-item self-rated inventories 170 
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assess anxiety and depression presence and severity in the past two weeks. Raw scores were 171 
converted to standardized T scores and interpreted as follows: T<55 (average symptoms); T=55-172 
59 (symptoms mildly elevated); T=60-69 (symptoms moderately elevated); T≥70 (symptoms 173 
extremely elevated).  174 
For young adults, the Beck Anxiety Inventory (BAI)47, a 21-item self-rated inventory, was used to 175 
measure the presence and severity of anxiety symptoms. Scores range from 0 to 63 and are 176 
interpreted as follow: 0-7 (minimal anxiety symptoms), 8-15 (mild anxiety symptoms), 16-25 177 
(moderate anxiety symptoms), 26-63 (severe anxiety symptoms). Presence and severity of 178 
depression symptoms in the past two weeks were measured using the 21-item self-rated Beck 179 
Depression Inventory II (BDI-II)47. Scores range from 0 to 63 with different levels being: 0-13 180 
(minimal depression symptoms); 14-19 (mild depression symptoms); 20-28 (moderate depression 181 
symptoms); 29-63 (severe depression symptoms). In further analyses, we defined significant 182 
anxiety as T score ≥ 55 (BYI-A) in adolescents and scores ≥ 8 (BAI) in young adults, and 183 
significant depression as T score ≥ 55 (BYI-D) in adolescents and scores ≥ 14 (BDI-II) in young 184 
adults.  185 
Psychological distress was measured with the visual analogic scale of the distress thermometer 186 
(DT)48,49. It is a 10-point self-rated screening tool assessing distress severity in the past 7 days. 187 
Scores range from 0 (absence of distress) to 10 (extreme distress). Participants who scored 4 or 188 
higher on the DT were coded as positive for distress. 189 
Assessment of functional health status 190 
Functional health status was investigated using the self-rated 16D (adolescents) and 15D 191 
(adults)50,51. These questionnaires measure current functional health status across 18 domains: 192 
mobility, vision, hearing, breathing, sleeping, eating, speech, usual activities, excretion, mental 193 
function, discomfort/symptoms, distress, depression, vitality, sexual activity, school, appearance, 194 
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and friendship. Usual activities and sexual activity domains are measured among adults 195 
exclusively while appearance, friendship, and school domains are specific to adolescents. In 196 
addition, to avoid confounding associations, depression and distress items were removed from the 197 
15D and 16D. For each domain, scores range from 1 (best level of function) to 5 (worst level of 198 
function). Raw scores are converted to a set of utility weights generating an index score on a 0 199 
(being dead) to 1 (perfect health) scale for each domain and a total score representing overall status. 200 
In further analyses problems in specific health domains were defined as raw scores >1. The overall 201 
status index score was reversed with higher scores indicating poorer overall status.  202 
 203 
Assessment of social functioning 204 
To approach social functioning, we used two subscales of the Pediatric Quality of Life Inventory- 205 
4.0 Generic Core Scales for adolescents and adults (PedsQL)52, i.e. social functioning, work/school 206 
functioning (5 items each). The PedsQL is a 23-item Likert scale evaluating subjective quality of 207 
life. Scores range from 0 (never) to 4 (almost always) and are transformed to a percentage scale 208 
where higher well-being is reflected by higher percentages. 209 
 210 
Data analysis 211 
Anxiety, depression symptoms and distress were considered as outcome variables and functional 212 
health domains and overall health status as explanatory variables. After describing frequencies for 213 
each measure, we computed multivariable binary logistic regression models in each age group to 214 
explain the odds of a psychological risk (first aim). Analyses were adjusted for sex, age, age at 215 
diagnosis and treatment risk status. To adjust for multiple testing in the first objective, statistical 216 
significance was set at p <0.01.  217 
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To explore the second aim, a principal component analysis (PCA, parallel analysis53) was 218 
performed to determine the common variation among the three outcome variables and the principal 219 
component score was used as an outcome variable. We then tested mediation using bootstrapping 220 
techniques, where social and work/school functioning were tested as mediators in significant and 221 
consistent relationships identified in the first aim (PROCESS path-analysis for SPSS54). We 222 
detected a mediation effect when zero was not included in the 95%CI and defined partial and 223 
complete mediation in line with current standards55. Percent mediation will be reported as the 224 
effect size of the indirect effect. Analyses were performed in the whole sample with age group as 225 
a control variable. 226 
 227 
   RESULTS 228 
Cohort characteristics 229 
Overall, 345 participants were contacted to participate in the study (Supplementary Figure S1). 230 
The participation rate was 83% with a return rate of 89%. The final study cohort consisted of 105 231 
adolescents aged 13-18 years and 182 adults aged 19+ years (Table 1). Adolescents had a mean 232 
age of 15.6 years (SD = 1.5) and adults 25.4 years (SD = 4.7). Mean time since diagnosis was 12 233 
years (SD = 2.6) for adolescents and 17 years (SD = 4.9) for adults. The majority of participants 234 
were French speaking (96%) and Caucasian (97%). Significant statistical differences were found 235 
between both groups on treatment risk status and radiotherapy with younger participants being 236 
rated less frequently as high-risk treatment status. This translated into a lower frequency of 237 
radiation therapy in participants treated more recently. No significant difference was noted on 238 






Psychological status  243 
Most participants reported normative levels on psychological symptoms. However, subgroups 244 
were identified as reporting internalizing problems (Fig. 1). Mild-severe levels of anxiety and 245 
depression were observed in 14% (adolescents) vs. 27% (young adults) and 21% (adolescents) 246 
vs. 20% (young adults) respectively. Significant distress was observed in 30% vs. 19% of 247 
adolescent vs. adult participants (χ2 =4.25, p<0.05).  248 
 249 
Functional health status  250 
Overall, participants reported high functional health status on the 16D and 15D with a mean 251 
composite score close to 1 (perfect health) and low variability: 0.91 ± 0.08 (adolescents) and 252 
0.92 ± 0.08 (adults). This indicates low severity of problems across health domains (Fig. 2). 253 
Among adolescents, the most frequently reported issues (rate of occurrence >25%) were 254 
appearance (55%), sleeping (50%), vitality (37%), vision (33%), discomfort/symptoms (30%) 255 
speech (29%) and breathing (25%). In the adult group, issues with in sleeping (48%), vitality, 256 
(41%), discomfort/symptoms (39%), breathing (37%) and mental function (29%) were most 257 
frequently reported. In contrast, very few participants from either group (<10%) reported issues 258 
with mobility, eating, hearing, and friendship with the latter domain assessed among adolescents 259 
only. When comparing frequencies across groups, adolescents reported issues with vision more 260 
frequently than adults (33% vs. 8%, p<0.001). 261 
 262 
Contributors to psychological risk  263 
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When exploring associations of potential controls (age, gender, age at diagnosis, treatment risk 264 
status) with psychological status, no control variables were associated with the odds of reporting 265 
significant levels of anxiety, depression or distress across the two age groups (p = 0.324). 266 
Anxiety. When adjusting for age, sex, age at diagnosis, and treatment risk status, we found 267 
significant associations of functional health status with anxiety. In adolescents, anxiety was 268 
associated with overall functional health status and specific issues with mental function, 269 
excretion, hearing, and sleeping (Table 2). The risk associated to issues with sleeping 270 
(OR=10.27) is important as this issue was particularly frequently reported (>25%). In adults, 271 
anxiety was also associated with overall functional status and it was associated with issues on 272 
vitality, discomfort/symptoms, usual activities, sexual activity, mobility, speech, mental function, 273 
and excretion (Table 3). Risks associated to issues of vitality (OR=8.49), discomfort/symptoms 274 
(OR=8.18), and mental function (OR=4.23) are also of importance as these issues were 275 
frequently reported (>25%). 276 
Depression. After adjusting for controls in adolescents, depression was associated with overall 277 
functional status and it was associated with issues with mental function, hearing, and breathing 278 
(Table 2). Risk associated with a breathing issue (OR = 9.62) is noteworthy as it was frequently 279 
reported (>25%). In adults, depression was associated with overall functional status and with 280 
issues with usual activities, discomfort/symptoms, sexual activity, mental function, excretion, 281 
and sleeping (Table 3). Risks associated with vitality (OR= 13.28), discomfort/symptoms 282 
(OR=7.44), mental function (OR=6.65) and sleeping (OR=3.91) are noticeable as these issues 283 
were particularly frequent (>25%). 284 
Distress. When exploring the same models predicting for distress, we found an association with 285 
overall functional status in both age groups. Among adolescents, distress was associated with 286 
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issues with mental function and sleeping (Table 2). Risk associated to issues with sleeping 287 
(OR=5.07) is meaningful as this issue was particularly frequent (>25%). Among adults, distress 288 
was associated with issues on mental function (OR=5.13), vitality (OR=3.92), and sleeping 289 
(OR=3.88) (Table 3). All these health issues were frequently reported (>25%). 290 
 291 
Mediating role of social and work/school functioning  292 
The main analyses revealed that the overall health status and mental function domains were 293 
consistently associated with anxiety, depression, and distress across age groups. Thus, the above-294 
mentioned health domains were selected for the present analysis. The PCA yielded one 295 
component summarizing 61% of the variance (raw data eigenvalue ≥1.18, KMO=0.645). 296 
Mediation analyses revealed a consistent pattern with the association of overall health status and 297 
mental function problems with psychological risk (component score) to be partially mediated by 298 
social and work/school functioning (Fig. 3). Concerning overall health status, the indirect effect 299 
of social functioning was 0.01 (PM = 0.17), BootCI [0.01-0.03] and the direct effect was 0.07 (p 300 
< 0.0001). For work/school functioning, the indirect effect was 0.02 (PM = 0.28), BootCI [0.01-301 
0.04], the direct effect was 0.06 (p < 0.0001). For mental function problems, the indirect effect of 302 
social functioning was 0.25 (PM= 0.22), BootCI [0.12-0.44] and the direct effect was 0.89 (p < 303 
0.0001). The indirect effect of work/school functioning was 0.42 (PM= 0.37). BootCI [0.25-0.63] 304 
and the direct effect was 0.72 (p = 0.0001). Importantly, there was no age-group effect 305 
suggesting results apply to both adolescents and adults alike.  306 
 307 
   DISCUSSION 308 
In a cross-sectional exploration of health status of 287 participants (105 adolescents and 182 309 
adults) who were successfully treated for cALL and ≥5 years post-diagnosis we found that 310 
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approximately 1 in 5 survivors experienced mild-severe anxiety, depression, and distress. 311 
Unspecific distress was more frequent among adolescents than adults (30% vs. 18%). Domains 312 
that were frequently reported and associated with psychological risk across outcomes were 313 
vitality, sleeping, discomfort/symptoms, and mental functioning. We also found from mediation 314 
analyses that the contribution of health status could be explained by its role on social 315 
functioning. 316 
Regarding adolescents, the rate of distress found is fairly similar to that of other studies 317 
performed in aftercare and during treatment. The fact that subjective unspecific distress was far 318 
more frequent than anxiety and depression may reflect how younger participants were 319 
experiencing psychological issues and suggests these issues were probably not adequately 320 
captured in symptom-specific psychological scales. Supporting this hypothesis, it has been 321 
suggested that anxiety and depression symptoms are not sufficient to describe the adolescent’s 322 
emotional burden associated with cancer as this can translate into a broader range of symptoms 323 
including anger or behavioral problems57,58. 324 
Among adult survivors distress was much lower in our sample than in another mixed CCS cohort 325 
(19% vs. 28.6%) 48, which could be explained by heterogeneity of cancer types, treatment and 326 
older age found in the previous cohorts possibly leading to more LAEs resulting in more distress. 327 
.  328 
Our results are consistent with the observation that anxiety is more salient than depression 329 
among adult survivors40,60,61,62. More generally, anxiety and depression have been found to be the 330 
most common psychological complaints among CCS63.  331 
Functional health status was high and homogeneous in the cohort (total scores approaching 332 
perfect health and minimal variation). However, our results revealed that cALL survivors 333 
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commonly reported vitality, sleeping, and discomfort/symptoms issues while several other health 334 
domain issues were specific to either age subgroups (e.g. appearance in adolescents and mental 335 
function in adults). The range of scores provided by the vitality health domain (feeling healthy 336 
and energetic to feeling extremely weary, tired or feeble, totally exhausted) can be interpreted as 337 
the level of fatigue. Cancer-related fatigue and sleep problems (sleep disturbance, sleep quality, 338 
daytime sleepiness) are among the most common late effects following cancer48,60,61,63-67. If left 339 
unmanaged, they can yield important work or school performance difficulties which may lead to 340 
significant distress, anxiety, depression, and impaired quality of life68-72. In fact, sleeping issues 341 
seemed to be key contributors to psychological health: both adolescents and adults in the present 342 
study were 2 to 10 times more likely to report anxiety, depression or distress if they had sleeping 343 
difficulty. Interestingly, despite similar percentages in reporting fatigue issues in both age 344 
groups, it  only seemed to be a key contributor to psychological risk among adults but not among 345 
adolescents. It can be hypothesized that this issue did not significantly disrupt adolescents’ daily 346 
activities or lead to social constraints compared to adults. Therefore, perhaps the younger 347 
group’s coping strategies (adaptive health competence beliefs) were more effective in promoting 348 
self-efficacy and preventing psychological burden.73-76.  349 
Discomfort/symptoms was also found to be frequent  among adolescents (39%) and adults (50%) 350 
. This health domain includes symptoms such as pain, aches, nausea, feeling sick, itching. Of 351 
particular interest, the  frequency of pain varies from 13% to 57% in similar CCS cohorts with 352 
common complaints being abdominal, neuropathic, headaches and neck and back pain77,78. 353 
Clinicians and researchers identify pain and discomfort as major domains for future quality of 354 
life. In long-term CCS, it has been associated with lower educational attainment, unemployment 355 
and single status and could lead to psychological risk77. 356 
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However, we found this domain to contribute to psychological risk only in adults. It is possible 357 
that pain was not recognized or reported similarly across age groupsor that adolescents had lesser 358 
pain-related disability compared to their adult counterparts.  359 
Alternatively, while issues with breathing were equally frequent in adolescents and adults (23% 360 
vs. 32%), they were found to contribute to depression only in the former group. This could 361 
reflect the importance of social limitations due to this health issue. In fact,  studies have revealed 362 
adolescent survivors with pulmonary issues to be less physically active than their siblings, 363 
limiting  their engagement in usual, age-appropriate activities and which could lead to impaired 364 
quality of life and negative mood79-81. 365 
We focused on frequently reported health issues. However, less frequently reported difficulties, 366 
such as mental function issues (reported in 17% and 25% of adolescents and adults, 367 
respectively), might have pervasive impacts as well. Mental function issues were consistently 368 
associated with psychological outcomes across age groups. Among adolescents, it was the 369 
strongest key contributor of anxiety (95%CI 3.43-70.47), depression (95%CI 3.98-97.54), and 370 
distress (95%CI 3.62-50.28). Mental function issues have been widely documented in CCS and a 371 
strong hypothesis to account for its relation to psychological symptoms and school/work 372 
achievement and social functioning9,43-45. Given the close relationship between neurocognitive 373 
functioning with fatigue68,69, it is also possible that both interact to explain psychological risk. 374 
When exploring the role of overall health status and mental function, we found that social and 375 
work/school functioning partially accounted for the association of overall health status and 376 
psychological risk. It could be argued that health status limitations prevented participants from 377 
engaging in usual activities, interacting with peers or colleagues and decreased ability to meet 378 
one’s goals, thereby contributing to psychological symptoms. Indeed, the recognition of one’s 379 
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own mental function difficulties on memory and attention may lead to lower self-esteem and 380 
self-efficacy at school/work. Subsequent limitations on school achievements, and professional 381 
goal attainments could contribute to social isolation, impaired social adjustments, and emotional 382 
distress9,43-45.  383 
This study presents a unique exploration of functional status and psychological risk in a young 384 
cohort including a subsample of adolescents with a French speaking cultural background. 385 
However, as analyses were performed separately in both age groups this limited statistical 386 
power. The comparison between both age groups can also be biased as the older group received 387 
more radiation therapy which is a known risk factor for LAEs.Furthermore, as the design was 388 
cross-sectional we could not draw causal inferences on observed associations as there is no 389 
certainty that physical health issues preceded psychological risk. It is possible that health 390 
functional status would partly reflect negative mood. Although we did control symptom overlap 391 
in contributors and outcomes, a longitudinal study design would be required to further confirm 392 
our results.  393 
In summary, our results offer new insights on levels and types of psychological risk in a 394 
homogeneous cohort of young survivors treated for cALL, with emotional distress being reported 395 
by 14% to 30% of our cohort. Our study further documents the important contribution of health 396 
functions such as vitality, sleep, discomfort/symptoms, and mental function to psychological risk 397 
in adolescent and adult cALL survivors as well as how social functioning impacts the relationship 398 
found between functional health status and psychological risk. Future studies should explore 399 
functional domains that are most often reported as problematic by young survivors as interventions 400 
targeting these are increasingly available for the adult population who faces cancer and should be 401 
adapted and proposed to CCS82,83. Lastly additional research should be conducted to explore 402 
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cancer rehabilitation programs targeting vocational achievement84 and social skills 403 
interventions85,86 to promote social functioning. 404 
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Figure 1 Frequency of anxiety, depression, and distress symptoms in adolescent and adult cALL 636 
participants 637 
For adolescents: N=95 for anxiety and depression, N= 98 for distress. Positive cases for anxiety 638 
and depression were defined as T scores >55 (results obtained with BYI anxiety and depression 639 
inventories). 640 
For adults: N=143 for anxiety and depression, N=157 for distress. Positive cases for anxiety were 641 
defined as BAI >7, positive cases for depression BDI-II >13 642 
For both groups, a cut-point of 4 was used for distress (results obtained with DT). 643 
 644 
Figure 2 Frequency of issues with domains of health status in adolescent and adult cALL 645 
participants 646 
For adolescents: N= 98. Results obtained from the 16D questionnaire. Domains exclusive to the 647 
16D: appearance, friendship and school 648 
23 
 
For adults: N=157. Results obtained from the 15D questionnaire. Domains exclusive to the 15D: 649 
sexual activity, usual activities. Absence of eating impairment for adults. 650 
For both questionnaires, scores range from 1 (best level of function) to 5 (worst level of 651 
function). Issues with health domains defined as scores >1.  652 
 653 
Figure 3 Mediation analysis for cALL participants 654 
 655 
Mediation analysis conducted with path analysis - PROCESS macro for SPSS (Hayes ref). Sample 656 
consists of adolescent (n=95) and adult (n=146) cALL survivors with the age group included as a 657 
covariable. Mental function problems’ score from the 16D and 15D questionnaires. Impairment is 658 
defined as scores >1. Work/school functioning score from Pediatric Quality of Life Inventory 659 
(PedsQL). Higher scores indicate better work/school functioning.  660 
a: estimate of the effect of the predictor (mental function impairment) on the mediator 661 
(work/school functioning).  662 
b: estimate of the effect of the mediator on the outcome variable (component score representing 663 
psychological risk). 664 
ab: indirect effect which is the product of path a and path b representing the amount of 665 
mediation. Significance of the indirect effect determined with bootstrapping method and to be 666 
interpreted as follows: if 0 is not included in the 95%CI, mediation has occurred and significant 667 
at the p < .05. 668 
c: direct effect of the predictor variable on the outcome variable controlling for the mediator. 669 
 670 
Supplementary Figure S1 Study structure and flow 671 
Study structure and flow 672 
Montreal treatment site: Sainte-Justine University Health Center (SJUHC, Montreal, Canada) 673 
Quebec treatment site: Laval University Health Center (CHUL, Quebec, Canada) 674 
  675 
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3.7 (2.3) 7.6(4.8) 6.2 (4.5) 
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Time since diagnosis, 
years  
12 (2.6) 17.9 (4.9) 15.7 (5.1) 
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a PED, Professional Education Diploma. 677 
b CEGEP is the first stage of higher education after high school, exclusively in province of 678 
Quebec, Canada. 679 
c UG/PG, Undergraduate/Postgraduate. 680 
d Other: Spanish, Vietnamese, Bulgarian, Romanian. 681 
e Dana-Farber Cancer Institute ALL Consortium protocols for children. Each protocol is labeled 682 
by the year of the clinical trials detailing the treatment regimen during the 4 phases of therapy 683 
(remission induction, CNS-directed treatment, Intensification and continuation). 684 
 685 




Anxiety (n= 94) 
 
Depression (n= 94) 
 
Distress (n= 96) 
 
Health status domains OR 95%CI P-value ORa 95%CIb P-value OR 95%CI P-value 
Mobilitya N/A N/A N/A N/A N/A N/A N/A N/A N/A 
Friendshipb   0.95 0.75-12.11 0.970 N/A N/A N/A 0.71 0.05-2.11 0.803 
Appearanceb   2.72        0.75-9.85 0.128 N/A N/A N/A 2.81 0.96-8.23 0.059 
School   4.88        1.07-22.31 0.041 0.64 0.08-5.01 0.673 1.17 0.25-5.37 0.842 
Vision   0.60        0.17-2.06 0.410 0.68 0.15-3.03 0.613 0.25 0.17-1.58 0.524 
Hearing 10.70 2.43-47.11 0.002 18.29  2.97-112.84 0.002 1.88 0.48-7.34 0.366 
Breathing   4.04 1.11-14.75 0.035 9.62 1.87-49.46 0.007 1.82 0.61-5.45 0.284 
Sleeping 10.27 2.39-44.03 0.002 3.94 0.84-18.52 0.083 5.07   1.70-15.17 0.004 
Eating 11.09               0.87-141.56            0.064   6.66     0.45-98.82            0.168 1.14   0.91-14.26 0.919 
Speech   4.43 1.40-14.06 0.011 2.84 0.73-10.99     0.131 1.19 0.43-3.28 0.734 
Excretion 11.42 2.36-55.21 0.002 8.20   1.58-42.42     0.012 1.56 0.41-5.95 0.517 
Mental function 15.55 3.43-70.47 <0.0001 19.71 3.98-97.54 <0.0001    13.48   3.62-50.28 <0.0001 
Discomfort/symptoms   2.19        0.68-7.03 0.187 2.34    0.61-8.96 0.214 3.45 1.28-9.31 0.014 
Vitality   2.53        0.79-8.10 0.117 7.35 1.40-38.74 0.019 3.32 1.21-9.09 0.019 
16D total scorec   1.36 1.16-1.60 <0.0001 1.32 1.13-1.60 <0.0001 1.17 1.07-1.30· 0.003 
ORs are adjusted for age, gender, age at diagnosis and treatment risk status in all analyses. 
P-values in bold indicate p < 0.01. 
a Analysis not applicable because the sample size for participants with mobility impairment and presence of distress, anxiety and depression was 
equal to 1. 
b Analysis not applicable as no participants with difficulties in this domain presented depression. 
c 16D total score scale change by multiplying reversed score values by a factor of 100, excluding depression and distress item scores due to their 
shared variance with the outcomes.  
Health status domains from the 16D questionnaire, scores range from 1 (best level of function) to 5 (worst level of function). Impairment defined 
as scores >1. 
Anxiety and depression scores from Beck Youth Inventories for anxiety and depression. Positive cases were defined as T scores >55. 










Anxiety (n= 142) 
 
Depression (n= 142) 
 




 ORa 95%CIb P-value ORa 95%CIb P-value ORa 95%CIb P-value 
Mobility  5.61 1.53-20.51   0.009   3.24 0.81-12.87  0.095 1.56 0.36-6.85 0.556 
Vision 3.49 1.00-12.16   0.050   4.88 1.34-17.71  0.016 0.57 0.07-4.9 0.605 
Hearing 3.05 0.99-9.42   0.052   1.78 0.49-6.44  0.378 1.33 0.32-5.57 0.690 
Breathing 1.86 0.85-4.09   0.121   1.38 0.57-3.35  0.480 1.69 0.71-4.0 0.237 
Sleeping 2.26 1.02-4.98   0.043   3.91 1.48-10.31  0.006 3.88 1.49-10.14 0.006 
Eatingd N/A N/A N/A 
Speech 4.82 1.91-12.20   0.001   2.66 0.98-7.16   0.054 2.47 0.92-6.62 0.072 
Excretion 3.79 1.56-9.19   0.003   4.48 1.68-11.95   0.003 1.03 0.36-2.96 0.964 
Usual activities 6.68 2.36-18.95 <0.0001 18.21 5.43-61.05 <0.0001 3.58 1.15-11.14 0.027 
Mental function 4.23 1.84-9.73   0.001   6.65 2.58-17.14 <0.0001 5.13 2.04-12.91 0.001 
Discomfort/symptoms 8.18 3.27-20.45 <0.0001   7.44 2.63-21.07 <0.0001 2.68 1.11-6.47 0.029 
Vitality 8.49 3.44-20.97 <0.0001 13.28 4.09-43.11 <0.0001 3.92 1.59-9.71 0.003 
Sexual activity 6.22 2.40-16.27 <0.0001   6.76 2.39-19.12 <0.0001 2.91 1.04-8.15 0.043 
15D total scoree 1.18 1.10- 1.25 <0.0001   1.19 1.11-1.28 <0.0001 1.10 1.04-1.17 0.001 
P values in bold indicate p < 0.01. 
a Odds Ratio. 
b 95% confidence interval. 
c ORs are adjusted for age, gender, age at diagnosis and treatment risk status. 
d Analysis not applicable because there were no participants with an eating impairment.  
e 15D total score scale change by multiplying reversed score values by a factor of 100. Total score excluding depression and distress item scores 
due to their shared variance with the outcomes.  
Health status domains from the 15D questionnaire, scores range from 1 (best level of function) to 5 (worst level of function). Impairment defined 
as scores >1. 
Anxiety and depression scores from Beck Anxiety and Depression inventories. Positive cases define as BAI >7 and BDI-II >13. 
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b = -0.06, p <0.0001
c’= 1.4, p <0.001
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